Ullrich H J, Döring K, Grüneberg U, Jähnig F, Trowsdale J, van Ham S M
Human Immunogenetics Laboratory, Imperial Cancer Research Fund, Holborn, London, United Kingdom.
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13163-8. doi: 10.1073/pnas.94.24.13163.
Antigenic peptide loading of major histocompatibility complex class II molecules is enhanced by lysosomal pH and catalyzed by the HLA-DM molecule. The physical mechanism behind the catalytic activity of DM was investigated by using time-resolved fluorescence anisotropy (TRFA) and fluorescence binding studies with the dye 8-anilino-1-naphthalenesulfonic acid (ANS). We demonstrate that the conformations of both HLA-DM and HLA-DR3, irrespective of the composition of bound peptide, are pH sensitive. Both complexes reversibly expose more nonpolar regions upon protonation. Interaction of DM with DR shields these hydrophobic domains from the aqueous environment, leading to stabilization of the DM and DR conformations. At lysosomal pH, the uncovering of additional hydrophobic patches leads to a more extensive DM-DR association. We propose that DM catalyzes class II peptide loading by stabilizing the low-pH conformation of DR, favoring peptide exchange. The DM-DR association involves a larger hydrophobic surface area with DR/class II-associated invariant chain peptides (CLIP) than with stable DR/peptide complexes, explaining the preferred association of DM with the former. The data support a release mechanism of DM from the DM-DR complex through reduction of the interactive surface, upon binding of class II molecules with antigenic peptide or upon neutralization of the DM-DR complex at the cell surface.
主要组织相容性复合体II类分子的抗原肽装载通过溶酶体pH值增强,并由HLA - DM分子催化。通过使用时间分辨荧光各向异性(TRFA)以及与染料8 - 苯胺基 - 1 - 萘磺酸(ANS)的荧光结合研究,对DM催化活性背后的物理机制进行了研究。我们证明,无论结合肽的组成如何,HLA - DM和HLA - DR3的构象都对pH敏感。两种复合物在质子化时都会可逆地暴露更多非极性区域。DM与DR的相互作用使这些疏水结构域免受水环境的影响,从而导致DM和DR构象的稳定。在溶酶体pH值下,额外疏水补丁的暴露导致更广泛的DM - DR结合。我们提出,DM通过稳定DR的低pH构象来催化II类肽装载,有利于肽交换。与稳定的DR/肽复合物相比,DM - DR结合涉及与DR/II类相关恒定链肽(CLIP)更大的疏水表面积,这解释了DM与前者的优先结合。数据支持在II类分子与抗原肽结合或在细胞表面使DM - DR复合物中和后,通过减少相互作用表面使DM从DM - DR复合物中释放的机制。